Influenza Concerns Highlights AJPB Week in Review


Top articles of the week from The American Journal of Pharmacy Benefits.

5. Gene Transfer Therapy Gets FDA Fast Track

RT-100 AC6 treats patients with heart failure with reduced ejection fraction. Read more.

4. Opioids Among Biggest Drug Safety Concerns of 2017

Institute for Safe Medication Practices releases annual review of the year’s biggest medication safety issues. Read more.

3. Gene Therapy Provides Hope for Patients with Hemophilia

A majority of patients with hemophilia B avoided joint bleeds after receiving gene therapy. Read more.

2. FDA Approves Short-Acting Follow-On Insulin

Ademlog (insulin lispro injection) approved to control blood glucose levels among patients with diabetes. Read more.

1. CDC Warns of Increase in Influenza Activity

Several influenza activity indicators were higher than is typically seen for this time of year. Read more.

Related Videos
Ozempic, obesity, drug shortage, media portrayal | Image Credit: zimmytws -
Collaborative Care Team for Diabetes, Cardiovascular Disease | Image Credit: Production Perig -
Pharmacist helping patient use glucose monitor -- Image credit: Kalyakan |
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin -
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin -
Cholesterol diet and healthy food eating nutritional concept with clean fruits in nutritionist's heart dish and patient's blood sugar control record with diabetic measuring tool | Image Credit: Chinnapong -
Image Credit: Pixel-Shot |
Image credit: Goffkein |
© 2024 MJH Life Sciences

All rights reserved.